Enterprise Value
134.7M
Cash
0.00
Avg Qtr Burn
N/A
Short % of Float
31.33%
Insider Ownership
8.01%
Institutional Own.
64.72%
Qtr Updated
09/30/22
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Veverimer (TRC101) Details Chronic kidney disease, Kidney disease | NDA Resubmission | |
Veverimer (TRC101) Details Chronic kidney disease, Kidney disease | Phase 3 Update |